Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Phospho-(Ser/Thr) ATM + ATR Substrate Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5117231

Catalog No. PIPA5117231


Only null left
Add to Cart

Description

Description

Positive Samples: Jurkat, NIH/3T3, C6.

Ataxia telangiectasia mutated kinase (ATM) and ataxia telangiectasia and Rad3-related kinase (ATR) are related kinases that regulate cell cycle checkpoints and DNA repair. The identified substrates for ATM are p53, p95/NBS1, MDM2, Chk2, BRCA1, CtIP, 4E-BP1, and Chk1. The essential requirement for the substrates of ATM/ATR is S*/T*Q. Hydrophobic amino acids at positions -3 and -1, and negatively charged amino acids at position +1 are positive determinants for substrate recognition by these kinases. Positively charged residues surrounding the S*/T*Q are negative determinants for substrate phosphorylation. The complex phenotype of AT cells suggests that it likely has additional substrates.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Phospho-(Ser/Thr) ATM + ATR Substrate
Polyclonal
Unconjugated
L(s/t)Q; SQ/TQ
A synthetic peptide corresponding to a sequence containing phosphorylated S & T.
100 μL
Primary
-20°C, Avoid Freeze/Thaw Cycles
Liquid
ELISA, Western Blot
1.65 mg/mL
PBS with 50% glycerol and 0.01% thimerosal; pH 7.3
Rabbit
Affinity chromatography
RUO
All species
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.